87 related articles for article (PubMed ID: 10053099)
1. Thymidine phosphorylase expression is predominantly observed in stroma of well-differentiated adenocarcinoma of endometrium and correlates with a frequency of vascular involvement.
Sakamoto H; Shirakawa T; Izuka S; Igarashi T; Kinoshita K; Ohtani K; Takami T; Nakayama Y; Teramoto K; Satoh K
Gynecol Oncol; 1999 Mar; 72(3):298-305. PubMed ID: 10053099
[TBL] [Abstract][Full Text] [Related]
2. Expression of thymidine phosphorylase is associated with a poor prognosis in patients with ductal adenocarcinoma of the pancreas.
Takao S; Takebayashi Y; Che X; Shinchi H; Natsugoe S; Miyadera K; Yamada Y; Akiyama S; Aikou T
Clin Cancer Res; 1998 Jul; 4(7):1619-24. PubMed ID: 9676835
[TBL] [Abstract][Full Text] [Related]
3. The expression of thymidine phosphorylase and its correlation with angiogenesis in gastric adenocarcinoma.
Ikeguchi M; Oka S; Saito H; Kondo A; Tsujitani S; Maeta M; Kaibara N
Anticancer Res; 1999; 19(5B):4001-5. PubMed ID: 10628344
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of tumor angiogenesis and thymidine phosphorylase tissue expression in patients with endometrial cancer.
Mazurek A; Kuc P; Terlikowski S; Laudanski T
Neoplasma; 2006; 53(3):242-6. PubMed ID: 16652195
[TBL] [Abstract][Full Text] [Related]
5. Correlation between expression levels of thymidine phosphorylase (dThdPase) and clinical features in human gastric carcinoma.
Kimura H; Konishi K; Kaji M; Maeda K; Yabushita K; Miwa A
Hepatogastroenterology; 2002; 49(45):882-6. PubMed ID: 12064013
[TBL] [Abstract][Full Text] [Related]
6. Aerodigestive tract invasion by well-differentiated thyroid carcinoma: diagnosis, management, prognosis, and biology.
McCaffrey JC
Laryngoscope; 2006 Jan; 116(1):1-11. PubMed ID: 16481800
[TBL] [Abstract][Full Text] [Related]
7. A role of thymidine phosphorylase and P53 tissue protein expression in biology of endometrial cancer.
Mazurek A; Kuć P; Mazurek-Wadołkowska E; Laudański T
Neoplasma; 2008; 55(3):261-5. PubMed ID: 18348659
[TBL] [Abstract][Full Text] [Related]
8. Angiogenic co-operation of VEGF and stromal cell TP in endometrial carcinomas.
Sivridis E; Giatromanolaki A; Anastasiadis P; Georgiou L; Gatter KC; Harris AL; Bicknell R; Koukourakis MI;
J Pathol; 2002 Apr; 196(4):416-22. PubMed ID: 11920737
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological significance of fragile histidine triad transcription protein expression in endometrial carcinomas.
Segawa T; Sasagawa T; Saijoh K; Inoue M
Clin Cancer Res; 2000 Jun; 6(6):2341-8. PubMed ID: 10873085
[TBL] [Abstract][Full Text] [Related]
10. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
[TBL] [Abstract][Full Text] [Related]
11. Angiogenesis and platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in endometrial cancer.
Seki N; Kodama J; Hongo A; Miyagi Y; Yoshinouchi M; Kudo T
Int J Oncol; 1999 Oct; 15(4):781-6. PubMed ID: 10493962
[TBL] [Abstract][Full Text] [Related]
12. 14-3-3sigma in endometrial cancer--a possible prognostic marker in early-stage cancer.
Ito K; Suzuki T; Akahira J; Sakuma M; Saitou S; Okamoto S; Niikura H; Okamura K; Yaegashi N; Sasano H; Inoue S
Clin Cancer Res; 2005 Oct; 11(20):7384-91. PubMed ID: 16243811
[TBL] [Abstract][Full Text] [Related]
13. Expression of the serine protease hepsin and clinical outcome of human endometrial cancer.
Matsuo T; Nakamura K; Takamoto N; Kodama J; Hongo A; Abrzua F; Nasu Y; Kumon H; Hiramatsu Y
Anticancer Res; 2008; 28(1A):159-64. PubMed ID: 18383840
[TBL] [Abstract][Full Text] [Related]
14. Expression of vascular endothelial growth factors (VEGF-A/VEGF-1 and VEGF-C/VEGF-2) in postmenopausal uterine endometrial carcinoma.
Hirai M; Nakagawara A; Oosaki T; Hayashi Y; Hirono M; Yoshihara T
Gynecol Oncol; 2001 Feb; 80(2):181-8. PubMed ID: 11161857
[TBL] [Abstract][Full Text] [Related]
15. Prognostic role of angiogenesis and its correlations with thymidine phosphorylase and p53 expression in ductal adenocarcinoma of the pancreas.
Jinfeng M; Kimura W; Sakurai F; Moriya T; Mizutani M; Hirai I
Hepatogastroenterology; 2007 Sep; 54(78):1635-40. PubMed ID: 18019682
[TBL] [Abstract][Full Text] [Related]
16. Clinical impact of thymidine phosphorylase expression in gastric cancer.
Noguchi T; Fujiwara S; Takeno S; Kai S; Mizuta A; Nagao Y; Uchida Y
Oncol Rep; 2003; 10(3):561-6. PubMed ID: 12684624
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological and prognostic significance of thymidine phosphorylase expression in gastric carcinoma.
Ogawa K; Konno S; Takebayashi Y; Miura K; Katsube T; Kajiwara T; Aiba M; Aikou T; Akiyama S
Anticancer Res; 1999; 19(5C):4363-7. PubMed ID: 10650777
[TBL] [Abstract][Full Text] [Related]
18. Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma.
Sivridis E; Giatromanolaki A; Gatter KC; Harris AL; Koukourakis MI;
Cancer; 2002 Sep; 95(5):1055-63. PubMed ID: 12209691
[TBL] [Abstract][Full Text] [Related]
19. Co-expression of vascular endothelial growth factor and thymidine phosphorylase in endometrial cancer.
Fujiwaki R; Hata K; Iida K; Maede Y; Watanabe Y; Koike M; Miyazaki K
Acta Obstet Gynecol Scand; 1999 Sep; 78(8):728-34. PubMed ID: 10468067
[TBL] [Abstract][Full Text] [Related]
20. The significance of the amount of myometrial invasion in patients with Stage IB endometrial carcinoma.
Alektiar KM; McKee A; Lin O; Venkatraman E; Zelefsky MJ; Mychalczak BR; McKee B; Hoskins WJ; Barakat RR
Cancer; 2002 Jul; 95(2):316-21. PubMed ID: 12124832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
